Unveiling resistance mechanisms to EGFR inhibitors in cholangiocarcinoma

Eitemau Tebyg

• Resiliency of lung cancers to EGFR inhibitor treatment unveiled offering opportunities to divide and conquer EGFR inhibitor resistance
  gan: Blakely, Collin M., et al.
  Cyhoeddwyd: (2012)
• Mechanisms of resistance to EGFR tyrosine kinase inhibitors
  gan: Huang, Lihua, et al.
  Cyhoeddwyd: (2015)
• Circulating tumour DNA and resistance mechanisms during EGFR inhibitor therapy in lung cancer
  gan: Escriu, Carles, et al.
  Cyhoeddwyd: (2016)
• Whacking a mole-cule: clinical activity and mechanisms of resistance to third generation EGFR inhibitors in EGFR mutated lung cancers with EGFR-T790M
  gan: Costa, Daniel B., et al.
  Cyhoeddwyd: (2015)
• Stressing the need to overcome EGFR tyrosine kinase inhibitor resistance
  gan: Toulabi, Leila, et al.
  Cyhoeddwyd: (2018)